Track topics on Twitter Track topics that are important to you
Unit 1A, Kingston Business Park
Phone: +44 (0) 1865 823823
Fax: +44 (0) 1865 821868
Adam Stoten, head of Technology Transfer at Isis Innovation (the technology transfer arm of the University of Oxford) discusses the recent successes of Oxford Sciences Innovation (OSI), a fund compris...
Gene and cell therapy group Oxford BioMedica has entered into an exclusive worldwide licensing agreement with Nasdaq-listed Axovant Sciences that will see the pair develop and commercialise OXB-102...
Biopharmaceutical firm Axovant Sciences has agreed exclusive worldwide rights for the development and commercialisation of gene therapy company Oxford BioMedica’s...Read More... The post Axovant buy...
Axovant Sciences Ltd. grossed $25mm through the private sale of 14.3mm common shares at $1.75 (a 17% premium) to parent Roivant Sciences. The company will use the proceeds to support development of OX...
The new Oxford Centre for Haematology has been launched with funding from the NIHR Oxford Biomedical Research Centre (BRC), bringing together University of Oxford researchers and clinicians from Oxfor...
Axovant Sciences has signed an exclusive worldwide licensing agreement with Oxford BioMedica to develop and commercialise, OXB-10, to treat Parkinson’s disease.
Oxford Vacmedix has secured $12.5M (€10M) to start its first clinical trials, joining other Oxford-based biotechs in the cancer vaccine field such as Vaccitech and SpyBiotech. Oxford Vacmedix has s...
Peer review is an essential part in the publication process, ensuring that Veterinary Sciences maintains high quality standards for its published papers[...].
The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...
Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...
The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...
The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...
Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty
Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...
Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...
Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...
Since 1977, Oxford Lasers has been supplying laser solutions to science and industry. Oxford Lasers was founded in 1977 by physicists from Oxford University whose research had been directed towards th...
s a professional clinical research organisation, OPS is committed to a culture of quality and excellence and applies best practice throughout the business.Working with major blue-chip clients, the com...
We have published hundreds of Oxford Pharmaceitical Sciences Limited news stories on BioPortfolio along with dozens of Oxford Pharmaceitical Sciences Limited Clinical Trials and PubMed Articles about Oxford Pharmaceitical Sciences Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Pharmaceitical Sciences Limited Companies in our database. You can also find out about relevant Oxford Pharmaceitical Sciences Limited Drugs and Medications on this site too.
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...